That's where that biology comes in
In the FLOW trial, which enrolled 3533 patients, treatment with Semaglutide (Table 2), a 24% reduction was observed in the urine albumin-to-creatinine ratio, alongside a decreased incidence of acute kidney injury, attenuation of CKD progression and a lower risk of progression to kidney transplantation
Here are some evidence-based strategies to support your health during the breastfeeding period: Medication alternatives: If you have an underlying condition like type 2 diabetes or insulin resistance, talk to your provider about medication alternatives that are safe to use postpartum
Traditional injectable formulations often reflect psychological and practical barriers to treatment initiation and continuation
However: Follow-up durations were typically 68 weeks
How to achieve precise dose adjustment and personalized treatment is currently a research focus